Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:20:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 removed, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-03-06T18:44:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new 'Moffitt Cancer Center Clinical Trials website' link and the sponsor organization name 'H. Lee Moffitt Cancer Center and Research Institute.' Introduced a new 'Helpful Links Provided by' section to house related links.
    Difference
    0.2%
    Check dated 2026-02-27T18:56:47.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Deleted the Study Protocol and Statistical Analysis Plan PDF along with several boilerplate/footer items from the study page.
    Difference
    20%
    Check dated 2026-02-20T16:55:00.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The update appears to be a site-wide template revision (Revision: v3.4.2) with removal of certain footer sponsor links; these changes do not modify the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-13T13:25:06.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The page revision updates from v3.4.0 to v3.4.1, with no substantive changes to study details, eligibility criteria, outcomes, or timelines.
    Difference
    0.1%
    Check dated 2026-02-06T09:09:59.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.